KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 158 filers reported holding KRYSTAL BIOTECH INC in Q4 2022. The put-call ratio across all filers is 6.89 and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,924 | -1.2% | 189 | 0.0% | 0.00% | – |
| Q2 2023 | $22,189 | +54.8% | 189 | +5.6% | 0.00% | – |
| Q1 2023 | $14,331 | -5.8% | 179 | -6.8% | 0.00% | – |
| Q4 2022 | $15,210 | -10.5% | 192 | -20.0% | 0.00% | – |
| Q3 2022 | $17,000 | -37.0% | 240 | -40.9% | 0.00% | – |
| Q2 2022 | $27,000 | -40.0% | 406 | -39.5% | 0.00% | – |
| Q1 2022 | $45,000 | -22.4% | 671 | -19.6% | 0.00% | – |
| Q4 2021 | $58,000 | +866.7% | 835 | +659.1% | 0.00% | – |
| Q3 2021 | $6,000 | 0.0% | 110 | +17.0% | 0.00% | – |
| Q2 2021 | $6,000 | -62.5% | 94 | -54.1% | 0.00% | – |
| Q1 2021 | $16,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q4 2020 | $12,000 | +33.3% | 205 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | +12.5% | 205 | 0.0% | 0.00% | – |
| Q2 2020 | $8,000 | – | 205 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $68,951,000 | 5.53% |
| S Squared Technology, LLC | 85,215 | $6,565,000 | 3.10% |
| First Light Asset Management, LLC | 491,511 | $37,866,000 | 2.51% |
| Soleus Capital Management, L.P. | 166,844 | $12,854,000 | 2.32% |
| Redmile Group, LLC | 2,060,132 | $158,713,000 | 2.24% |
| Nicholas Investment Partners, LP | 304,689 | $23,473,000 | 1.64% |
| HighMark Wealth Management LLC | 17,192 | $1,324,000 | 1.06% |
| DSAM Partners (London) Ltd | 70,274 | $5,414,000 | 1.00% |
| Artal Group S.A. | 500,000 | $38,520,000 | 0.68% |
| Hood River Capital Management LLC | 237,882 | $18,326,000 | 0.59% |